Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pharmaceutical Industry

Tag: Pharmaceutical Industry

According to a new analysis, the average monthly premium for enrollees in Medicare Part D prescription drug plans would increase to $42.17, up from $38.57. (AP Photo/Danny Johnston) Healthcare

Medicare drug premiums to jump 9 percent in 2017

Robert King · October 17, 2016 4:59 pm
Hillary Clinton, John Kerry and former Democratic senators Tom Harkin and Max Baucus heavily lobbied Biogen, which was the maker of the drug Tysabri. (AP Photo) Healthcare

WikiLeaks: Dems tried to get donor experimental drug

Robert King · October 17, 2016 4:49 pm
Anthem reported it's spending more money on medical costs to cover sicker-than-expected Obamacare enrollees. (AP Photo/Michael Conroy, File) Healthcare

Insurer won’t cover drug for rare kids’ disease

Robert King · October 7, 2016 6:26 pm
Mylan has drawn bipartisan anger for raising the price of the EpiPen by 400 percent since acquiring it in 2007. The price tag now runs $600 for a two-pack of the life-saving drug. (AP Photo/Pablo Martinez Monsivais) Healthcare

EpiPen maker racking up taxpayer dollars

Robert King · October 6, 2016 6:30 pm
Two-thirds or more of respondents in a new poll favor policies to bring down prescription prices. (AP Photo/Rich Pedroncelli) Healthcare

Americans favor policies to lower drug prices

Paige Winfield Cunningham · September 29, 2016 7:00 am
Lawmakers want to know if Mylan defrauded Medicaid by classifying the EpiPen as a generic drug. (George Frey/Bloomberg) Healthcare

Senators ask Justice Department to investigate EpiPen maker

Robert King · September 28, 2016 4:47 pm
Premiums for Medicare's prescription drug plans are expected to rise by about 4 percent next year, a new analysis found. (AP Photo/Rich Pedroncelli,file) Healthcare

Seniors to pay more for Medicare Part D next year

Robert King · September 28, 2016 4:05 pm
"I think it will have to be pushed into the next session," Cummings said. (Graeme Jennings/Examiner) Healthcare

Cummings: Action on high drug prices appears unlikely

Robert King · September 22, 2016 4:36 pm
"They raised the prices, I believe, to get filthy rich at the expense of our constituents," said Rep. Elijah Cummings of Maryland, the top Democrat on the committee. (Graeme Jennings/Examiner) Healthcare

Cummings: EpiPen CEO raised prices to get ‘filthy rich’

Robert King · September 21, 2016 7:40 pm
Mylan acquired the patent for EpiPen in 2007, becoming the sole seller and marketer of this life-saving medication. (Daniel Acker/Bloomberg) Healthcare

Washington’s monopoly policy

Deane Waldman · September 15, 2016 1:23 pm
Martin Shkreli tweeted his demand on the same day the House Oversight and Government Reform Committee announced a Sept. 21 hearing to scrutinize the price increase of allergy treatment EpiPens. (AP Photo) Healthcare

Pharma’s Shkreli wants immunity to testify to Congress

Robert King · September 14, 2016 7:19 pm
GAO finds that 300 generic drugs had at least one price hike of 100 percent or more since 2010. (AP Photo/Matt Rourke) Healthcare

Senators lament spikes in generic drugs

Robert King · September 14, 2016 6:43 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 142
  • ›Next page
Page 110 of 142
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement